Processa Pharmaceuticals, Inc.
PCSA
$0.2294
-$0.0059-2.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -74.69% | -57.85% | -35.80% | -16.95% | -27.64% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.34% | 85.97% | 56.28% | -41.96% | -50.81% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.74% | -38.82% | -24.44% | -19.80% | -32.84% |
|
|
|||||
| Total Current Assets | -66.74% | -38.82% | -24.44% | -19.80% | -32.84% |
| Net Property, Plant & Equipment | -49.06% | -41.96% | -37.37% | -33.16% | -34.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23,172.73% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -44.19% | -38.85% | -24.67% | -20.01% | -32.87% |
|
|
|||||
| Total Accounts Payable | 182.70% | 105.52% | 298.79% | 43.80% | -4.85% |
| Total Accrued Expenses | 295.56% | 104.15% | 62.25% | -70.42% | -63.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -12.68% | 14.51% | 13.80% | 10.47% | 5.96% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -0.05% |
| Total Other Current Liabilities | -- | -- | -- | -- | -0.05% |
| Total Current Liabilities | 109.77% | 47.59% | 88.91% | -53.23% | -26.84% |
|
|
|||||
| Total Current Liabilities | 109.77% | 47.59% | 88.91% | -53.23% | -26.84% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -99.25% | -97.52% | -76.58% | -60.82% | -55.58% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 92.24% | 33.52% | 69.47% | -53.65% | -30.60% |
|
|
|||||
| Common Stock & APIC | 10.61% | 10.04% | 8.82% | 10.88% | 12.00% |
| Retained Earnings | -15.72% | -15.80% | -14.42% | -14.39% | -17.31% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -66.00% | -48.09% | -34.24% | -12.41% | -33.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -66.00% | -48.09% | -34.24% | -12.41% | -33.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -66.00% | -48.09% | -34.24% | -12.41% | -33.22% |
|
|
|||||